Department of Applied Pharmaceutical Sciences and Clinical Pharmacy, Faculty of Pharmacy, 108568Isra University, Amman, Jordan.
Department of Biology, College of Science, 48144King Khalid University, Abha, Saudi Arabia.
Toxicol Ind Health. 2022 Dec;38(12):789-800. doi: 10.1177/07482337221133881. Epub 2022 Oct 17.
Gold nanoparticles (Au NPs) are used in diagnostic and therapeutic applications together with a variety of industrial purposes and in many biomedical sectors with potential risks to human health. The present study aimed to the histological, histochemical, and ultrastructural alterations induced by Au NPS in vital organs. Healthy male Wistar Albino rats () were subjected to 20 injections of 10-nm Au NPs at a daily dose of 2 mg/kg. Liver, kidney, heart, and lung biopsies from control and Au NPs-treated rats under study were subjected to histological and histochemical examinations. In comparison with the control rats, the renal tissue of Au NPs-treated rats demonstrated glomerular congestion, interstitial inflammatory cell infiltration, renal tubular hydropic degeneration, cloudy swelling, necrosis, and hyaline cast precipitation. In addition, Au NPs induced the following hepatic alterations: hepatocyte cytolysis, cytoplasmic vacuolation, hydropic degeneration, and nuclear alterations together with sinusoidal dilatation. Moreover, the hearts of the treated rats demonstrated myocarditis, cardiac congestion, hyalinosis, cardiomyocyte hydropic degeneration, myofiber disarray and cardiac congestion. The lungs of Au NPs-treated rats also exhibited the following pulmonary alterations: alectasis, emphysema, inflammatory cell inflammation, thickened alveolar walls, pulmonary interstitial edema, congestion, hypersensitivity, fibrocyte proliferation, and honeycombing. In conclusion, exposure to Au NPs induced histological, histochemical and ultrastructural alterations in the vital organs that may alter the function of these organs. Additional efforts are needed for better understanding the potential risks of Au NPs to human health.
金纳米粒子(Au NPs)在诊断和治疗应用中与各种工业用途一起使用,并且在许多生物医学领域中具有对人类健康的潜在风险。本研究旨在研究 Au NPS 在重要器官中引起的组织学、组织化学和超微结构改变。健康雄性 Wistar 白化大鼠()接受了 20 次 10nm Au NPs 注射,每天剂量为 2mg/kg。对对照和 Au NPs 处理的大鼠的肝、肾、心和肺活检进行了组织学和组织化学检查。与对照大鼠相比,Au NPs 处理的大鼠的肾组织显示肾小球充血、间质炎性细胞浸润、肾小管水肿变性、浑浊肿胀、坏死和透明栓子沉淀。此外,Au NPs 诱导了以下肝改变:肝细胞溶解、细胞质空泡化、水肿变性和核改变以及窦状扩张。此外,处理大鼠的心脏表现出心肌炎、心脏充血、玻璃样变性、心肌细胞水肿变性、肌纤维排列紊乱和心脏充血。Au NPs 处理大鼠的肺也表现出以下肺改变:肺泡萎陷、肺气肿、炎性细胞炎症、肺泡壁增厚、肺间质水肿、充血、过敏、成纤维细胞增殖和蜂窝肺。总之,暴露于 Au NPs 会在重要器官中引起组织学、组织化学和超微结构改变,从而改变这些器官的功能。需要进一步努力更好地了解 Au NPs 对人类健康的潜在风险。